Showing results (3291-3300 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|January 1, 1985
Synergistic anti-suppressor effect of mini cells prepared from Salmonella typhimurium and mitomycin C in EL 4-bearing miceS Kurashige, Y Akuzawa, S Mitsuhashi
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Lack of suppressive activity of human primary melanoma cells on the activation of autologous lymphocytesD Taramelli, A Mazzocchi, C Clemente, et al.
Cancer Immunology, Immunotherapy : CII|January 18, 2021
Tumor-draining lymph nodes are survival niches that support T cell priming against lymphatic transported tumor antigen and effects of immune checkpoint blockade in TNBCMeghan J O'Melia, Margaret P Manspeaker, Susan N Thomas
Cancer Immunology, Immunotherapy : CII|January 29, 2021
The predictive value of body mass index on prognosis and adverse events of cancers treated with immunotherapy: a systematic review and meta-analysisYafei You, Chang Jiang, Kunwei Peng, et al.
Cancer Immunology, Immunotherapy : CII|February 4, 2021
IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunityMin Yang, Esther Giehl, Chao Feng, et al.
Cancer Immunology, Immunotherapy : CII|January 15, 2022
Antibody-dependent cellular phagocytosis of tropomyosin receptor kinase C (TrkC) expressing cancer cells for targeted immunotherapyPhei San Lai, Syed Muhammad Usama, Lik-Voon Kiew, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Specificity of the generation and expression of enhanced anti-plasmacytoma immunity by spleen cells from melphalan-treated MOPC-315 tumor bearersM B Mokyr, E Barker
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Suppression of both macrophage-mediated tumor cell lysis and cytolytic factor production by a factor (CIF) derived from normal embryonic fibroblastsR Gallily, G E Gifford, J Loewenstein
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Incidence and growth of methylcholanthrene-induced tumors in mice with altered immunological statusC Trutin-Ostović, M Golubić, M Matović, et al.
Cancer Immunology, Immunotherapy : CII|January 18, 2022
Novel inhibitor of hematopoietic cell kinase as a potential therapeutic agent for acute myeloid leukemiaFernanda Marconi Roversi, Maura Lima Pereira Bueno, Juliete Aparecida Francisco da Silva, et al.
Pageof 652